Demonstration zone conducts special training on adverse reactions to drugs and medical devices
Release time:
2024-06-24
To further solidify the responsibility of reporting adverse reactions to drugs and medical devices, improve the business level of regulatory departments, and ensure the safety of public drug, device, and cosmetic use, the Demonstration Zone Market Supervision Bureau recently conducted a special training session on adverse reactions to drugs and medical devices. 32 pharmacies and 6 hospitals (health centers) in the area participated in the training.

The training invited Xu Di and Meng Ping from the Nantong Municipal Adverse Drug Reaction Center to give special lectures. They conducted in-depth analysis of adverse drug reactions, guidance on filling out medical device adverse event monitoring reports, and common problems. They also provided detailed explanations of the basic concepts, current status, and relevant regulations of adverse reaction/event monitoring. On-site interactive exchanges and Q&A sessions were held with the trainees.
The meeting reported on the situation of adverse drug and medical device reaction reporting in 2023. Based on three aspects: target tasks, work requirements, and regulatory publicity, the meeting deployed the work of drug and medical device adverse reaction/event monitoring for 2024. It emphasized the need to improve staff's reporting awareness, strengthen organizational leadership, clarify responsibilities, and ensure the effectiveness of adverse reaction/event monitoring work, effectively improving the quantity and quality of adverse reaction/event reports.
This training further enhanced the understanding of drug and medical device business and use units regarding the importance of adverse drug reaction and medical device adverse event monitoring and reporting. It effectively improved the standardization of adverse reaction/event reporting. Next, the Market Supervision Bureau will continue to strengthen its inspection and supervision of various drug and medical device business and use units to ensure that the monitoring work of adverse drug and medical device reactions/events achieves tangible results.
Relevant personnel from the Demonstration Zone Market Supervision and Administration Bureau, the Sanyu Sub-bureau, and the Health Supervision Office participated in the training.
Let us help you.
Contact Us